| CASE REPORT |
|
| Year : 2022 | Volume
: 2
| Issue : 3 | Page : 700-703 |
|
|
Refractory bilateral choroiditis due to presumed ocular tuberculosis responding to intravitreal moxifloxacin
Kalpana Babu, Dhwani Shah, Krishna R Murthy
Department of Ophthalmology, Vittala International Institute of Ophthalmology & Prabha Eye Clinic and Research Center, Bangalore, Karnataka, India
Correspondence Address:
Dr. Kalpana Babu
Prabha Eye Clinic & Research Centre, 504, 40th Cross, Jayanagar 8th block, Bangalore - 560 070, Karnataka
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ijo.IJO_3052_21
|
|
|
A rare presentation of bilateral refractory choroiditis due to presumed ocular tuberculosis with dramatic response to intravitreal moxifloxacin is described in this report. A 32-year-old lady with a past history of bilateral choroiditis due to presumed ocular tuberculosis and biopsy-proven tubercular lymphadenitis four years ago came to us with reactivation of inflammation refractory to antitubercular therapy, systemic steroids, vitrectomy and intravitreal anti-VEGF injections. The lesions responded dramatically to intravitreal injections of moxifloxacin and dexamethasone. Following this dramatic response, she also received oral moxifloxacin 800 mg/day along with ATT for a year. At two-year follow-up, she is doing well with no further recurrences. To the best of our knowledge, no cases of tubercular choroiditis responding to moxifloxacin have been reported (MEDLINE search). This case highlights the usefulness of intravitreal moxifloxacin in refractory tubercular choroiditis.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
